Minimum of 150 Sites within 24 months in Namibia Over $60M USD Agreement 100% 4G coverage for Rural and Suburban QUEBEC, QC / April 14, 2022 / NuRAN Wireless Inc. (“NuRAN Wireless”) (CSE:NUR)(OTC:NRRWF)(FSE:1RN), a leading supplier of […]
This integration of the Company’s 3D and AR SaaS offerings in one login portal marks a major milestone with substantial SaaS revenue implications TORONTO, April 14, 2022—Nextech AR Solutions Corp. (“Nextech” or the “Company”) (OTCQB: NEXCF) […]
29% increase in Twirla cycles27% increase in total prescriptions (TRx) of Twirla PRINCETON, N.J., April 14, 2022– Agile Therapeutics, Inc. (NASDAQ: AGRX), a women’s healthcare company, today announced Twirla prescription data for the first quarter […]
NEW YORK, April 13, 2022 — Creatd, Inc. (NASDAQ: CRTD) (“Creatd” or the “Company”), a creator-first holding company, today announced the launch of a new partnership between Dune Glow Remedy (“Dune”), the Company’s owned-and-operated wellness beverage brand, and international […]
atai Life Sciences N.V. (NASDAQ: ATAI) Q4 2021 Earnings Highlights CEO Florian Brand: “…2021 was a truly transformative year for atai. We made important progress across our programs, expanded our diverse pipeline with multiple shots […]
Also Presenting Today at WSR Next Super Stock LIVE! (OTCQB:NEXCF) (CSE: NTAR) TORONTO, April 12, 2022—-Nextech AR Solutions Corp. (“Nextech” or the “Company”) (OTCQB: NEXCF) (NEO: NTAR) (CSE: NTAR) (FSE: N29), a Metaverse Company and leading […]
Definitive agreement reached to formalize a carbon credits sourcing arrangement with Malaysia-based asset manager Radiance Asset Berhad has agreed to introduce select carbon credit project owners to DeepMarkit for minting of carbon credits using the MintCarbon.io […]
PASADENA, CA, April 12, 2022 — LIXTE Biotechnology Holdings, Inc. (NASDAQ: LIXT), a clinical-stage pharmaceutical company focused on developing and commercializing cancer therapies, announces that Professor René Bernards, Netherlands Cancer Institute (NKI), Amsterdam, presented new data […]
— Independent Data Monitoring Committee Unanimously Recommends that Phase 3 Clinical Trial for Sabizabulin for Treatment of Hospitalized COVID-19 Patients at High Risk for ARDS Be Stopped Early Due to Overwhelming Evidence of Efficacy — […]
Treatment with HT-KIT prevented cancer cell growth and induced death in neoplastic mast cells over 72 hours HT-KIT inhibits tumor growth and systemic organ infiltration using both an allograft mastocytosis model and a humanized xenograft […]
Topline data expected within two months Blinded, interim data to be presented at the Undersea & Hyperbaric Medical Society’s Annual Scientific Meeting in May 2022 CHARLOTTESVILLE, Va., April 11, 2022 — Diffusion Pharmaceuticals Inc. (NASDAQ: […]
Launch reservations establish targeted flight schedule through 2023 SAN JOSE, Calif., April 07, 2022—Momentus Inc. (NASDAQ: MNTS) (“Momentus” or the “Company”), a U.S. commercial space company that plans to offer transportation and other in-space infrastructure […]
NEW YORK, NY / April 8, 2022 / Guardforce AI Co., Limited (“Guardforce AI” or the “Company”) (NASDAQ:GFAI)(NASDAQ:GFAIW), an integrated security solutions provider, today announced it has entered into a mutual agreement with Blue Pin (HK) Limited […]
MARLBOROUGH, Mass., April 8, 2022 — Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company developing the next generation of therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today presented positive new preclinical […]
Prototype medical device engineered to deliver sustained, sub-psychedelic quantities of candidate DMT-analogues In vitro, time dependent drug elution profile evaluated for three candidate molecules Biocompatibility of drug-loaded medical device demonstrates cell-based safety at doses anticipated […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
